Some patients remain on treatment long term, while others transition to maintenance strategies that emphasize nutrition, exercise, strength training, and healthy lifestyle habits
However, the larger issue is that many people see the new drugs as a quick-fix solution
Zhang Y, Gao Y, Fang K, Ye JJ, Ruan YH, Yang XJ, et al
This triple-action mechanism distinguishes it from existing approved agents such as semaglutide (a GLP-1 receptor agonist, approved in the UK as Wegovy and Ozempic) and tirzepatide (a dual GIP/GLP-1 agonist, approved as Mounjaro)
Genuine symptoms directly attributable to B12 overdose are poorly documented and exceptionally rare
Glutathione deficiency has been associated with impaired immune responses in some studies